Home About us Contact
|
Home About us Contact | ||
|
|
||
Conventional Cancer Treatment (conventional + cancer_treatment)
Selected AbstractsFactors Influencing the Decision to Forego Conventional Cancer TreatmentEUROPEAN JOURNAL OF CANCER CARE, Issue 4 2002Article first published online: 19 DEC 200 First page of article [source] Cancer, chitosan nanoparticles and catalytic nucleic acidsJOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATI ONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Issue 1 2009Mei Lin Tan Abstract Objectives The aim of this review was to examine gene therapy involving DNAzyme and siRNA encapsulation into chitosan nanoparticles, discussing the current and future status of this drug delivery system in enhancing drug delivery and cancer therapy. Key findings Cancer is a disease state in which the cells in our body undergo mutations at the genetic level and are transformed, acquiring the ability to replicate limitlessly. Conventional cancer treatment involves the use of surgery and cytotoxic chemotherapy and/or radiotherapy, which have the potential of harming normal, otherwise healthy, non-neoplastic cells. Newer forms of therapy such as immunotherapy and gene therapy have shown initial promise, but still require better ways to limit exposure to cancerous lesions in the body. As a result drug delivery systems have been developed in attempts to deliver therapeutics specifically to the target lesion site. One recent drug delivery system has revolved around the use of chitosan nanoparticle technology, where therapeutics are encapsulated into nanoparticles and targeted to tumours. Summary Though few, attempts at encapsulating therapeutics such as deoxyribozymes and small or short interfering RNA have been optimistic and encouraging. [source] Exploring the decision to forgo conventional cancer treatment by men with prostate cancer: a 3-year mixed-methods studyFOCUS ON ALTERNATIVE AND COMPLEMENTARY THERAPIES AN EVIDENCE-BASED APPROACH, Issue 2006MJ Verhoef [source] Cross-calibration of X-ray µCT and MRX for tissue analysisPROCEEDINGS IN APPLIED MATHEMATICS & MECHANICS, Issue 1 2009H. Rahn Ferrofluids are being considered as an aid for local cancer treatments, such as Magnetic Drug Targeting (MDT) and Magnetic Hyperthermia (MHT). Both methods make use of the strong influence of a magnetic field on the nanoparticles, with the aim of treating the cancer locally while reducing, or even eliminating, the side effects that usually occur during conventional cancer treatments. Microcomputed tomography analysis has been performed on tumour tissue after MDT and MHT in order to examine the distribution of the magnetic nanoparticles within the tissue. The majority of the measurements has been performed in a laboratory based on a polychromatic X-ray source. The strong energy dependence of the attenuation coefficient and the occurrence of the so called beam hardening artefacts make the quantitative evaluation of data acquired with polychromatic tomography equipment very difficult. In this paper we present a cross-calibration method for magnetorelaxometry and polychromatic X-ray tomography for biological tissue samples enriched with magnetic nanoparticles. (© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim) [source] | ||||||||||